TO BRING TOGETHER AN UNPRECEDENTED RETINAL IMAGE DATABASE TO STIMULATE COLLABORATIVE RESEARCH AMONG ACADEMIC INSTITUTIONS, CLINICAL PRACTICES, INDUSTRY PARTNERS, AND POTENTIALLY GOVERNMENT AGENCIES. TO INCREASE UNDERSTANDING OF THE GLOBAL DIVERSITY OF AMD, DEVELOP NOVEL BIOMARKERS AND ENDPOINTS FOR DISEASE PROGRESSION, AND FACILITATE THE DEVELOPMENT OF DIAGNOSTICS AND THERAPEUTICS FOR PATIENTS.